Predictors of clinical deterioration during hospitalization following acute ischemic stroke

European Neurology

Volumn 67, Issue 3, 2012, Pages 186-192

  Lin, Leng Chieh ^a,e   Lee, Tsong Hai ^c   Chang, Chien Hung ^c   Chang, Yeu Jhy ^c   Liou, Chia Wei ^d   Chang, Ku Chou ^d   Lee, Jiann Der ^d   Peng, Tsung Yi ^d   Chung, Jacky ^b   Chen, Shih Che ^b   Yang, Jen Tsung ^b,d  

^a Department of Emergency Medicine ^*  (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c Stroke Center and Department of Neurology   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^e CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Acute ischemic stroke; Albumin; Hemoglobin; Hospitalization; Neurologic deterioration; Risk factor

Indexed keywords

ALBUMIN; HEMOGLOBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOCHEMISTRY; BLOOD RHEOLOGY; BRAIN ISCHEMIA; EMERGENCY WARD; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RANKIN SCALE; STROKE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; DISEASE PROGRESSION; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 84862806489     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000334723     Document Type: Article

References (32)

1. Baron JC: Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications. Cerebrovasc Dis 2001; 11(suppl 1):2-8.
2. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview. Stroke 2001; 32: 2426-2432. (Pubitemid 32954818)
3. Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, Lyden PD, Broderick JP, Kwiatkowski TG, Fineberg SE, NINDS rt-PA Stroke Study Group: Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002; 59: 669-674.
4. Barber M, Langhorne P, Rumley A, Lowe GD, Stott DJ: Hemostatic function and progressing ischemic stroke: D-dimer predicts early clinical progression. Stroke 2004; 35: 1421-1425. (Pubitemid 38697469)
5. Sumer M, Ozdemir I, Erturk O: Progression in acute ischemic stroke: Frequency, risk factors and prognosis. J Clin Neurosci 2003; 10: 177-180. (Pubitemid 36358361)
6. Dávalos A, Cendra E, Teruel J, Martinez M, Genís D: Deteriorating ischemic stroke: Risk factors and prognosis. Neurology 1990; 40: 1865-1869.
7. Toni D, Fiorelli M, Gentile M, Bastianello S, Sacchetti ML, Argentino C, Pozzilli C, Fieschi C: Progressing neurological deficit secondary to acute ischemic stroke. A study on predictability, pathogenesis, and prognosis. Arch Neurol 1995; 52: 670-675.
8. Dávalos A, Toni D, Iweins F, Lesaffre E, Bastianello S, Castillo J: Neurological deterioration in acute ischemic stroke: Potential predictors and associated factors in the European cooperative acute stroke study (ECASS) I. Stroke 1999; 30: 2631-2636.
9. Jongbloed L: Prediction of function after stroke: A critical review. Stroke 1986; 17: 765-776. (Pubitemid 16066554)
10. Tei H, Uchiyama S, Ohara K, Kobayashi M, Uchiyama Y, Fukuzawa M: Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project. Stroke 2000; 31: 2049-2054.
11. Dávalos A, Castillo J, Pumar JM, Noya M: Body temperature and fibrinogen are related to early neurological deterioration in acute ischemic stroke. Cerebrovasc Dis 1997; 7: 64-69. (Pubitemid 27129338)
12. Silvestrelli G, Parnetti L, Paciaroni M, Caso V, Corea F, Vitali R, Capocchi G, Agnelli G: Early admission to stroke unit influences clinical outcome. Eur J Neurol 2006; 13: 250-255.
13. Roquer J, Rodríguez-Campello A, Gomis M, Jiménez-Conde J, Cuadrado-Godia E, ViVanco R, Giralt E, Sepúlveda M, Pont-Sunyer C, Cucurella G, Ois A: Acute stroke unit care and early neurological deterioration in ischemic stroke. J Neurol 2008; 255: 1012-1017.
14. Lin LC, Yang JT, Weng HH, Hsiao CT, Lai SL, Fann WC: Predictors of early clinical deterioration after acute ischemic stroke. Am J Emerg Med 2011; 29: 577-581.
15. Irace C, Ciamei M, Crivaro A, Fiaschi E, Madia A, Cortese C, Gnasso A: Hematocrit is associated with carotid atherosclerosis in men but not in women. Coron Artery Dis 2003; 14: 279-284. (Pubitemid 36900656)
16. Wannamethee G, Perry IJ, Shaper AG: Haematocrit, hypertension and risk of stroke. J Intern Med 1994; 235: 163-168. (Pubitemid 24208127)
17. Tanne D, Molshatzki N, Merzeliak O, Tsabari R, Toashi M, Schwammenthal Y: Anemia status, hemoglobin concentration and outcome after acute stroke: A cohort study. BMC Neurol 2010; 10: 22.
18. Diedler J, Sykora M, Hahn P, Heerlein K, Schölzke MN, Kellert L, Bösel J, Poli S, Steiner T: Low hemoglobin is associated with poor functional outcome after non-traumatic, supratentorial intracerebral hemorrhage. Crit Care 2010; 14:R63.
19. Velcheva I, Antonova N, Titianova E, Daminanov P, Dimitrov N, Dimitrova V: Hemorheological disturbances in cerebrovascular disease. Clin Hemorheol Microcirc 2008; 39: 391-396.
20. Jeong SK, Cho YI, Duey M, Rosenson RS: Cardiovascular risk of anemia correction with erythrocyte stimulating agents: Should blood viscosity be monitored for risk assessment? Cardiovasc Drugs Ther 2010; 24: 151-160.
21. Bath P, Chalmers J, Powers W, Beilin L, Davis S, Lenfant C, Mancia G, Neal B, Whitworth J, Zanchetti A, International Society of Hypertension Writing Group: International Society of Hypertension (ISH): Statement on the management of blood pressure in acute stroke. J Hypertens 2003; 21: 665-672. (Pubitemid 36549655)
22. Mattle HP, Kappeler L, Arnold M, Fischer U, Nedeltchev K, Remonda L, Jakob SM, Schroth G: Blood pressure and vessel recanalization in the first hours after ischemic stroke. Stroke 2005; 36: 264-268. (Pubitemid 40170805)
23. Leonardi-Bee J, Bath PM, Philips SJ, Sandercock PA, IST Collaborative Group: Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002; 33: 1315-1320. (Pubitemid 34517053)
24. Vemmos KN, Tsivgoulis G, Spengos K, Zakopoulos N, Synetos A, Manios E, Konstantopoulou P, Mavrikakis M: U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. J Intern Med 2004; 255: 257-265. (Pubitemid 38241370)
25. Geeganage CM, Bath PM: Relationship between therapeutic changes in blood pressure and outcomes in acute stroke: A metaregression. Hypertension 2009; 54: 775-781.
26. Lisk DR, Grotta JC, Lamki LM, Tran HD, Taylor JW, Molony DA, Barron BJ: Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography. Arch Neurol 1993; 50: 855-862. (Pubitemid 23229313)
27. Willmot M, Leonardi-Bee J, Bath PM: High blood pressure in acute stroke and subsequent outcome: A systematic review. Hypertension 2004; 43: 18-24. (Pubitemid 38031905)
28. COSSACS Trial Group: COSSACS (Continue or Stop post-Stroke Antihypertensives Collaborative Study): Rationale and design. J Hypertens 2005; 23: 455-458.
29. Potter J, Robinson T, Ford G, James M, Jenkins D, Mistri A, Bulpitt C, Drummond A, Jagger C, Knight J, Markus H, Beevers G, Dewey M, Lees K, Moore A, Paul S, CHHIPS Trial Group: CHHIPS (Controlling Hypertension and Hypotension Immediately Post- Stroke) Pilot Trial: Rationale and design: J Hypertens 2005; 23: 649-655. (Pubitemid 40684725)
30. Berge E, Aakvik R, Terent A, Boysen G: Scandinavian Candesartan Acute Stroke Trial (SCAST). Cerebrovasc Dis 2006; 21: 124-125.
31. ENOS Trial Investigators: Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: Rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122). Int J Stroke 2006; 1: 245-249.
32. Anderson CS, Huang Y, Wang JG, Arima H, Neal B, Peng B, Heeley E, Skulina C, Parsons MW, Kim JS, Tao QL, Li YC, Jiang JD, Tai LW, Zhang JL, Xu E, Cheng Y, Heritier S, Morgenstern LB, Chalmers J, INTERACT Investigators: Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): A randomised pilot trial. Lancet Neurol 2008; 7: 391-399.